| University of Wisconsin, B.A. | |
| Northwestern University’s Kellogg Graduate School of Management, MBA |
Dr. Fortune has over 30 years of experience in the healthcare, life sciences and information technology sectors including R&D, business development, manufacturing, information technology and general management responsibilities. He has been a Partner at Boston Millennia Partners since 2002. He was previously President and Chief Operating Officer of New Era of Networks (Nasdaq: NEON); Vice President at Monsanto; Vice President at Bristol Myers Squibb; Group President at Baxter International; and VP R&D at Baxter International. Dr. Fortune, currently serves on the boards of directors of CombinatoRx, Inc. (NasdaqGM: CRXX); EPIX Pharmaceuticals, Inc. (NasdaqGM: EPIX); and PAREXEL International Corp. (NasdaqGS: PRXL) as well as several private life sciences companies. He has been responsible for nurturing start-up activities from idea to prototype to standalone business and has been involved in some 30 M&A transactions from sourcing the company to closing the deal and ensuring successful integration. Dr. Fortune has also served on the engineering and scientific advisory boards of the University of Wisconsin, the University of Illinois, and the University of Chicago, and currently serves on the Industrial Advisory Board of the Cleveland Clinic Foundation and on the Commercial Advisory Board of the Global Cardiovascular Innovation Center of the Cleveland Clinic.
